Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/13786
Title: Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile
Authors: Karnaukh, E.V.
Polikov, H.O.
Zavgorodniy, A.S.
Keywords: genetic engineering, pharmaceuticals, Subalin, Roferon-А, IFN, Altevir
Issue Date: Sep-2016
Citation: Karnaukh E. V. Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile [Electronic resource] / E. V. Karnaukh, H. O. Polikov, A. S. Zavgorodniy // European Student Scientific Journal. – 2016. – № 2. – Access mode: sjes.esrae.ru/ru/26-376.
Abstract: Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).
URI: http://repo.knmu.edu.ua/handle/123456789/13786
ISSN: 2310-3094
Appears in Collections:Наукові праці. Кафедра фармакології та медичної рецептури

Files in This Item:
File Description SizeFormat 
опубликована англ стаття ESSJ 2016 #2.doc1,79 MBMicrosoft WordView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.